好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Lessons from a Patient Advisory Board: Barriers & Faciliators to Post-Stroke Blood Pressure Control
Cerebrovascular Disease and Interventional Neurology
P12 - Poster Session 12 (11:45 AM-12:45 PM)
14-014

To identify barriers and facilitators to post-stroke blood pressure (BP) control among a diverse group of stroke survivors.

Blood pressure (BP) reduction is the most important opportunity for secondary stroke prevention. Despite the benefit of controlling BP after stroke, many patients fail to achieve adequate control. For instance, >60% of patients with stroke discharged from our institution have uncontrolled BP. In October 2023, the Yale Patient & Family Advisory Council (PFAC) was assembled to understand barriers to post-stroke BP control and opportunities for improvement.

Patients with ischemic and hemorrhagic stroke were recruited to participate along with their care-partners in the PFAC. Patients were reimbursed monetarily for their time. Segments of agenda-driven meetings utilized semi-structured interviewing techniques. Discussions were recorded, transcribed, and analyzed according to the framework method to identify key themes related to post-stroke BP control.

Twelve stroke survivors were enrolled in the PFAC (33% female; 33% Black, 9% Hispanic, 56% White; mean age 62 years old). Meetings were held over a video platform. Survivors reported “information overload,” reduced concentration, increased anxiety, and impaired ability to retain information delivered during their hospitalization. There was value for care-partner involvement, noting that the support of family members was essential for reinforcing BP management strategies. Lastly, survivors identified peer support as the most promising BP intervention that would overcome barriers specific to stroke survivors. Members recommended programs to be held in community locations (libraries or gyms) to foster comfort and accessibility compared to clinical environments. There was also preference for conversational discussion over lectures to promote mutual learning and engagement.

Listening and engaging with stroke survivors identified barriers to BP control as well as a preferred intervention for overcoming the unique barriers faced by patients with stroke. Next steps include tailoring the peer support program in partnership with the PFAC and the local community.

Authors/Disclosures
Rachel Kitagawa (Yale School of Medicine)
PRESENTER
Ms. Kitagawa has nothing to disclose.
Sofia Constantinescu, BS Ms. Constantinescu has nothing to disclose.
Kevin N. Sheth, MD, FAAN (Yale UniversityDivision of Neuro and Critical Care) Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Daniel F. Sarpong Dr. Sarpong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NYU Langone Medical Center. Dr. Sarpong has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association ATVB Journal.
Erica S. Spatz, MD Dr. Spatz has nothing to disclose.
Adam De Havenon, MD, FAAN (Yale University) Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Rachel Forman, MD (Yale Neurology) Dr. Forman has nothing to disclose.